These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17204458)

  • 1. Theoretical calculation of triazolam hydroxylation and endogenous steroid inhibition in the active site of CYP3A4.
    Torimoto N; Ishii I; Hata M; Kobayashi Y; Nakamura H; Ariyoshi N; Kitada M
    Biochim Biophys Acta; 2007 Feb; 1774(2):223-32. PubMed ID: 17204458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triazolam substrate inhibition: evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site.
    Schrag ML; Wienkers LC
    Drug Metab Dispos; 2001 Jan; 29(1):70-5. PubMed ID: 11124232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct interaction between substrates and endogenous steroids in the active site may change the activity of cytochrome P450 3A4.
    Torimoto N; Ishii I; Hata M; Nakamura H; Imada H; Ariyoshi N; Ohmori S; Igarashi T; Kitada M
    Biochemistry; 2003 Dec; 42(51):15068-77. PubMed ID: 14690416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent alteration of the CYP3A4 active site: evidence for multiple substrate binding domains.
    Schrag ML; Wienkers LC
    Arch Biochem Biophys; 2001 Jul; 391(1):49-55. PubMed ID: 11414684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition and stimulation of intestinal and hepatic CYP3A activity: studies in humanized CYP3A4 transgenic mice using triazolam.
    van Waterschoot RA; Rooswinkel RW; Sparidans RW; van Herwaarden AE; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Dec; 37(12):2305-13. PubMed ID: 19752211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
    Nakamura H; Nakasa H; Ishii I; Ariyoshi N; Igarashi T; Ohmori S; Kitada M
    Drug Metab Dispos; 2002 May; 30(5):534-40. PubMed ID: 11950784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5.
    Patki KC; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Jul; 31(7):938-44. PubMed ID: 12814972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helices F-G are important for the substrate specificities of CYP3A7.
    Torimoto N; Ishii I; Toyama K; Hata M; Tanaka K; Shimomura H; Nakamura H; Ariyoshi N; Ohmori S; Kitada M
    Drug Metab Dispos; 2007 Mar; 35(3):484-92. PubMed ID: 17178770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topological alteration of the CYP3A4 active site by the divalent cation Mg(2+).
    Schrag ML; Wienkers LC
    Drug Metab Dispos; 2000 Oct; 28(10):1198-201. PubMed ID: 10997940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grapefruit juice, lyophilized grapefruit juice, and powdered whole grapefruit inhibit cytochrome P450-mediated triazolam hydroxylation by beagle dog liver microsomes.
    Hanley MJ; Cerundolo R; Radwanski N; Court MH
    J Vet Pharmacol Ther; 2010 Apr; 33(2):189-95. PubMed ID: 20444044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazolam substrate inhibition: evidence of competition for heme-bound reactive oxygen within the CYP3A4 active site.
    Schrag ML; Wienkers LC
    Adv Exp Med Biol; 2001; 500():347-50. PubMed ID: 11764967
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of interaction between citalopram and the CYP3A4 substrate triazolam.
    Nolting A; Abramowitz W
    Pharmacotherapy; 2000 Jul; 20(7):750-5. PubMed ID: 10907965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam.
    Sugimoto K; Araki N; Ohmori M; Harada K; Cui Y; Tsuruoka S; Kawaguchi A; Fujimura A
    Eur J Clin Pharmacol; 2006 Mar; 62(3):209-15. PubMed ID: 16416305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam.
    Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of buffer conditions on CYP2C8-mediated paclitaxel 6α-hydroxylation and CYP3A4-mediated triazolam α- and 4-hydroxylation by human liver microsomes.
    Kudo T; Ozaki Y; Kusano T; Hotta E; Oya Y; Komatsu S; Goda H; Ito K
    Xenobiotica; 2016; 46(3):241-6. PubMed ID: 26290405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of age on in vitro triazolam biotransformation in male human liver microsomes.
    Patki KC; von Moltke LL; Harmatz JS; Hesse LM; Court MH; Greenblatt DJ
    J Pharmacol Exp Ther; 2004 Mar; 308(3):874-9. PubMed ID: 14634046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Disposition of Triazolam and Clobazam in Humanized CYP3A Mice with a Double-Knockout Background of Mouse
    Kobayashi K; Minegishi G; Kuriyama N; Miyajima A; Abe S; Kazuki K; Kazuki Y
    Drug Metab Dispos; 2023 Feb; 51(2):174-182. PubMed ID: 36379710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midazolam and triazolam biotransformation in mouse and human liver microsomes: relative contribution of CYP3A and CYP2C isoforms.
    Perloff MD; von Moltke LL; Court MH; Kotegawa T; Shader RI; Greenblatt DJ
    J Pharmacol Exp Ther; 2000 Feb; 292(2):618-28. PubMed ID: 10640299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.